Login
$KPTI
$0.44 -$0.04 (8.82%) Live

Company Executives

$KPTI Management Team

Mr. Brendan Strong

Senior Vice President - Investor Relations and Corporate Communications

Age -
Compensation -
Sex Male

Mr. Richard Paulson

President

Chief Executive Officer

Director

Age 57
Compensation $2.069M USD
Sex Male

Ms. Lori Macomber

Executive Vice President

Chief Financial Officer

Treasurer

Age 54
Compensation -
Sex Female

Ms. Sohanya Cheng

Executive Vice President

Chief Commercial Officer

Age 42
Compensation $1.095M USD
Sex Female

Mr. Stuart Poulton

Executive Vice President

Chief Development Officer

Age 52
Compensation $1.109M USD
Sex Male

Dr. Reshma Rangwala

Executive Vice President

Chief Medical Officer

Age 47
Compensation $1.124M USD
Sex Female

Mr. Michael Mano

Senior Vice President

General Counsel

Secretary

Age 48
Compensation $2.060M USD
Sex Male
Directors
7
serving now
Independent
6 of 7
stated in the proxy
Average tenure
8.6 years
from year joined
CEO also chairs the board
Not stated
no chair stated
Director Age On board Independent Committees Other public boards 2025 pay Source
Barry E. Greene
62 2013
13 years
Independent None stated None stated $130,142
Christy J. Oliger
56 2020
6 years
Independent None stated Nuvalent, Inc. $95,142
Deepika R. Pakianathan, Ph.D.
61 2013
13 years
Independent None stated Theravance Biopharma, Inc., Mereo Biopharma Group PLC $105,142
Richard Paulson
58 2020
6 years
Not independent None stated None stated Paid as CEO
Chen Schor
53 2020
6 years
Independent None stated Adicet Bio, Inc. $85,142
Garen G. Bohlin
78 2013
13 years
Independent None stated Collegium Pharmaceutical, Inc. $95,142
Zhen Su, M.D.
49 2023
3 years
Independent None stated CytomX Therapeutics, Inc. $75,142

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

3 disclosed in the proxy filed Apr 13, 2026
Entities advised or subadvised by T. Rowe Price Investment Management, Inc. ("T. Rowe")
$4,999,999.72

Purchased 850,238 shares of common stock and warrants to purchase 753,012 shares in the October 2025 Private Placement.

J. Wood Capital Advisors LLC
Approximately $1.91 million
October 2025

Issued 326,667 shares of common stock and warrants to purchase 215,906 shares in satisfaction of consideration owed for financial advisory services in connection with the Financing Transactions.

each of our directors
each of our directors
Amount not stated

Indemnification agreements requiring the company to indemnify each director for certain expenses, judgments, fines and settlements arising from service as a director.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support